MENU
DAWN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Day One Biopharmaceuticals (DAWN) Earnings Date & Reports

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company... Show more

A.I. Advisor
published Earnings

DAWN is expected to report earnings to rise 15.34% to -33 cents per share on November 10

Day One Biopharmaceuticals DAWN Stock Earnings Reports
Q3'25
Est.
$-0.33
Q2'25
Beat
by $0.06
Q1'25
Beat
by $0.07
Q4'24
Missed
by $0.17
Q3'24
Beat
by $0.70
The last earnings report on August 05 showed earnings per share of -28 cents, beating the estimate of -35 cents. With 497.56K shares outstanding, the current market capitalization sits at 624.83M.
View a ticker or compare two or three
DAWN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. DAWN showed earnings on August 05, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2000 Sierra Point Parkway
Phone
+1 650 484-0899
Employees
155
Web
https://www.dayonebio.com